X0203 3 2009-01-09 0 0001125699 DAIS ANALYTIC CORP DLYT.OB 0001404598 Platinum-Montaur Life Sciences, LLC 152 WEST 57TH STREET 54TH FLOOR NEW YORK NY 10019 0 0 1 0 0001339643 Nordlicht Mark 152 W. 57TH STREET 54TH FLOOR NEW YORK NY 10019 0 0 1 0 Secured Convertible Promissory Note 0.20 2007-12-31 Common Stock 3000000 D 2007 Stock Purchase Warrant 0.25 2007-12-31 2012-12-31 Common Stock 3000000 D These shares of Common Stock and derivatives to acquire Common Stock are beneficially owned by Platinum-Montaur Life Sciences, LLC (?Platinum-Montaur?). Mark Nordlicht is the controlling person of Platinum-Montaur. As a result, Mr. Nordlicht may be deemed, pursuant to Rule 13d-3 of the Securities Exchange Act of 1934, as amended, to be a beneficial owner of all the shares of Common Stock directly or indirectly held by Platinum-Montaur. By virtue of his position as the Managing Member of Platinum-Montaur, Mr. Nordlicht has the sole power to vote and dispose of the Issuer?s securities, including shares of Common Stock and derivatives to acquire Common Stock, directly held by Platinum-Montaur. The Secured Convertible Promissory Note remains exercisable to the extent not paid after the applicable maturity date. /s/ MARK NORDLICHT Managing Member 2009-11-03 /s/ MARK NORDLICHT 2009-11-03